These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients. Kaplinsky E, González-Costello J, Manito N, Roca J, Barbosa MJ, Nebot M, Salazar-Mendiguchia J, Berdejo J, Mañas P, Miralles A, Cequier A. Transplant Proc; 2012 Nov 27; 44(9):2564-6. PubMed ID: 23146455 [Abstract] [Full Text] [Related]
14. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group. Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978 [Abstract] [Full Text] [Related]
18. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Corman SL, Coley KC, Schonder KS. Pharmacotherapy; 2006 Oct 27; 26(10):1433-7. PubMed ID: 16999653 [Abstract] [Full Text] [Related]
19. Transplantation: impact of pretransplant renal insufficiency. Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, Bloom RD, Reddy KR. Liver Transpl; 2008 May 27; 14(5):665-71. PubMed ID: 18433034 [Abstract] [Full Text] [Related]
20. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED. Transplantation; 2006 Aug 15; 82(3):368-74. PubMed ID: 16906035 [Abstract] [Full Text] [Related] Page: [Next] [New Search]